LOS ANGELES--(BUSINESS WIRE)--Cougar Biotechnology, Inc. (NASDAQ: CGRB) today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at Leerink Swann’s Roundtable Conference, “Conquering Cancer with Novel Therapeutics,” on Friday, May 9, at 12:55 p.m. EDT at The Grand Hyatt Hotel in New York City. Mr. Auerbach will provide a company overview and update on the status of Cougar’s current clinical development programs.
